Heparin stops necrosis from cobra bites, potentially improving survival rates, say University of Sydney and Liverpool researchers. Published in Science Translational Medicine, it neutralises toxins. Annually, snake bites cause 1.4 lakh deaths, 4 lakh long-term effects in India, Africa. Professors Neely and Casewell noted heparin’s impact versus current antivenoms, aligning with WHO’s 2030 goal. Quick implementation possible.